You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

34 Items

Systemic Treatment Emergency Preparedness Guidance Document

Document Status: Current

Aug 2025

The Continued Use of Trastuzumab Beyond Disease Progression in Patients with Metastatic Breast Cancer

Document Status: Archived
ID: CED 13

Jun 2009

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

The Use of Bevacizumab in Metastatic Breast Cancer

Document Status: Archived
ID: CED 12

Apr 2009

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Document Status: Archived
ID: CED 8

Jul 2008

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Document Status: Archived
ID: CED 10

Sep 2008

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

Treatment of Chronic Myeloid Leukemia with Imatinib

Document Status: Archived
ID: 6-15

Dec 2013

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Document Status: Current
ID: GL 6-A-2023-1
Version: 2

Updated

Jan 2026

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Document Status: In-Review
ID: 7-9
Version: 2

Apr 2014